US private equity (PE) firm Platinum Equity has acquired a controlling stake in Inventia Healthcare’s core Oral Solid Dosage (OSD) business from PE firm Invascent’s India Life Sciences Fund III, New York Life Investment Management's Jacob Ballas India Fund III and affiliates of the company's founding Shah family.
¬ Haymarket Media Limited. All rights reserved.
